Novartis AG NVSEF:OTC Pink - Current Information

Last Price$85.55NASDAQ Previous Close - as of 3:08PM ET 9/24/20

Today's Change-2.74(3.10%)
Bid (Size)$85.05 (100)
Ask (Size)$88.05 (100)
Day Low / High$85.55 - 87.40
Volume1.8 K
 

Read more news Recent News

No news stories available at this time.

Company Profile

Business DescriptionNovartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland. View company web site for more details
AddressLichtstrasse 35
Basel, Basel-Stadt (Basle Town) 4056
Phone+41.61.324.11.11
Number of Employees125,161
Chief Executive OfficerVasant Narasimhan
Chief Financial OfficerHarry Werner Kirsch
Chief Technology & Digital OfficerElizabeth Theophille
Chief Medical OfficerJohn Tsai

Company Highlights

Price Open$87.40
Previous Close$88.29
52 Week Range$68.65 - 98.00
Market Capitalization$211.1 B
Shares Outstanding2.5 B
SectorHealth Technology
IndustryPharmaceuticals: Major
Current Dividend / Yield$2.95 / 3.61%
Dividend Ex-Date03/03/2020
Dividend Pay-Date03/05/2020
Dividend Yield 5 Year Average3.39%
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings28.49
Earnings per Share$3.14
Beta vs. S&P 500N/A
Revenue$51.9 B
Net Profit Margin14.96%
Return on Equity13.56%